RE: TYK2 Pre-clinical completion1 Jul 2020 12:37
All of the above. Just 200,000 shares this time. Last time had 3.5m at 0.17. It was a recommendation by a work colleague. I think it was around 2010 when one of their drugs was tested successfully on mice it went to4.5p. When the penny dropped that human clinical trials could be years off it halved and I sold out and still I did really well but then went on to lose a lot of it on Clontarf. Sareum was probably beginners luck and went on to learn the hard way about AIM .I've followed this on and off for the last few years and yes know there are long term investors here.